Attune Neurosciences
PrivateLast Round
Grant
Apr 10, 2026
Total Funding Raised
$4.72M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Attune Neurosciences operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Grant round in April 2026.
Attune Neurosciences is a medical device company that develops non-invasive neurostimulation products to treat central nervous system disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Government Contracts, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Attune Neurosciences Comparables
Compare Attune Neurosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Highland Instruments | 83% | |
| Soterix Medical | 79% | |
| Neurosona | 78% |
For institutional investors. Book with your work email.
Attune Neurosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 10, 2026 | ||||
| Accelerator | Feb 21, 2025 | ||||
| Grant | Sep 20, 2022 | ||||
| Seed | Oct 4, 2021 | ||||
| Grant | Sep 30, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Attune Neurosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| One Mind | Accelerator |
| Genoa Ventures | Seed |
| ARPA-H | Grant |
| Prime Movers Lab | Seed |
| Satori Capital | Seed |
| National Institute on Drug Abuse | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 854% MoM, reaching 26.9K.
- Aug 16, 2026
Grew 33% QoQ from 15 to 20 employees.
For institutional investors. Book with your work email.
Attune Neurosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Attune Neurosciences's valuation, stock price, and market status.
Is Attune Neurosciences a public or private company?
Attune Neurosciences is a private company.
What is the current stock price of Attune Neurosciences?
Attune Neurosciences is a private company, so its shares have no public market price. Caplight tracks Attune Neurosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Attune Neurosciences worth (valuation)?
Valuation information for Attune Neurosciences is not publicly available.
Can I buy Attune Neurosciences stock?
Attune Neurosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Attune Neurosciences's last funding round?
Attune Neurosciences's most recent funding round was Grant on April 10, 2026.
Who are the main investors in Attune Neurosciences?
Key investors in Attune Neurosciences include One Mind.
Will Attune Neurosciences IPO soon?
No public IPO plans have been announced for Attune Neurosciences.
How can I track Attune Neurosciences secondary market activity?
Caplight tracks bids, offers, and trades in Attune Neurosciences's shares on secondary markets.